What’s new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis

Awareness, proper diagnosis and treatment of cardiac amyloidosis have increased, but there are still several unmet needs that have to be addressed for the optimal care of the disease. In this comprehensive review, we describe current and future treatments for both hereditary and wild-type TTR cardia...

Full description

Saved in:

Bibliographic Details
Published in:	Therapeutic advances in cardiovascular disease Vol. 18; p. 17539447241295957
Main Authors:	Zaidel, Ezequiel J., Song, Sol C., Sterba, Juan J., Piccinato, Agustina, Ramos, María Candelaria, Cacia, Silvina L.
Format:	Journal Article
Language:	English
Published:	Sage UK: London, England SAGE Publications 01-01-2024 SAGE Publishing
Subjects:	Review
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Awareness, proper diagnosis and treatment of cardiac amyloidosis have increased, but there are still several unmet needs that have to be addressed for the optimal care of the disease. In this comprehensive review, we describe current and future treatments for both hereditary and wild-type TTR cardiac amyloidosis and also review lifestyle, including current challenges and opportunities for specific dietary concerns and exercise sports for these patients.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	1753-9447 1753-9455 1753-9455
DOI:	10.1177/17539447241295957